Japan Animal Referral Medical Center Co., Ltd. (TYO:6039)
Japan · Delayed Price · Currency is JPY 1,041.00
-4.00 (-0.38%)
Aug 27, 2026, 3:30 PM JST
TYO:6039 Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 6,363 | 6,192 | 5,277 | 4,270 | 3,872 | 2,979 | |
Revenue Growth | 15.68% | 17.34% | 23.58% | 10.28% | 29.98% | 4.64% |
Cost of Revenue | 3,717 | 3,685 | 3,445 | 2,806 | 2,430 | 1,873 |
Gross Profit | 2,645 | 2,507 | 1,832 | 1,464 | 1,442 | 1,106 |
Selling, General & Admin | 1,279 | 1,231 | 999 | 868 | 758 | 576 |
Other Operating Expenses | 102 | 102 | 88 | 69 | 68 | 59 |
Operating Expenses | 1,405 | 1,357 | 1,111 | 967 | 862 | 666 |
Operating Income | 1,241 | 1,150 | 721 | 497 | 580 | 440 |
Interest Expense | -43.88 | -36 | -26 | -19 | -17 | -13 |
Other Non Operating Income (Expenses) | 37.87 | 31 | 25 | 31 | -13 | 11 |
EBT Excluding Unusual Items | 1,235 | 1,145 | 720 | 509 | 550 | 438 |
Gain (Loss) on Sale of Assets | -4 | -4 | -1 | -18 | -17 | -1 |
Asset Writedown | -0.21 | - | - | - | - | - |
Other Unusual Items | - | - | - | - | - | -15 |
Pretax Income | 1,230 | 1,141 | 719 | 491 | 533 | 422 |
Income Tax Expense | 337.91 | 308 | 199 | 154 | 153 | 136 |
Net Income | 892.42 | 833 | 520 | 337 | 380 | 286 |
Net Income to Common | 892.42 | 833 | 520 | 337 | 380 | 286 |
Net Income Growth | 49.48% | 60.19% | 54.30% | -11.32% | 32.87% | 0.35% |
Shares Outstanding (Basic) | 13 | 13 | 13 | 14 | 12 | 12 |
Shares Outstanding (Diluted) | 13 | 13 | 13 | 14 | 12 | 12 |
Shares Change | 0.05% | -0.34% | -6.73% | 11.92% | 2.18% | -0.26% |
EPS (Basic) | 69.05 | 64.45 | 40.15 | 24.59 | 31.21 | 24.11 |
EPS (Diluted) | 69.05 | 64.45 | 40.15 | 24.25 | 30.64 | 23.60 |
EPS Growth | 49.41% | 60.54% | 65.55% | -20.85% | 29.83% | 0.87% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | -954 | 418 | -141 | 82 | -44 |
Free Cash Flow Per Share | - | -73.82 | 32.23 | -10.14 | 6.60 | -3.62 |
Dividend Per Share | 12.000 | 12.000 | 7.400 | 4.000 | - | - |
Dividend Growth | 62.16% | 62.16% | 85.00% | - | - | - |
Gross Margin | - | 40.49% | 34.72% | 34.29% | 37.24% | 37.13% |
Operating Margin | 19.50% | 18.57% | 13.66% | 11.64% | 14.98% | 14.77% |
Profit Margin | 14.03% | 13.45% | 9.85% | 7.89% | 9.81% | 9.60% |
Free Cash Flow Margin | - | -15.41% | 7.92% | -3.30% | 2.12% | -1.48% |
EBITDA | 1,833 | 1,738 | 1,291 | 961 | 991 | 681 |
EBITDA Margin | - | 28.07% | 24.46% | 22.51% | 25.59% | 22.86% |
D&A For EBITDA | 592.5 | 588 | 570 | 464 | 411 | 241 |
EBIT | 1,241 | 1,150 | 721 | 497 | 580 | 440 |
EBIT Margin | - | 18.57% | 13.66% | 11.64% | 14.98% | 14.77% |
Effective Tax Rate | - | 26.99% | 27.68% | 31.36% | 28.71% | 32.23% |